{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:49:28Z","timestamp":1780490968516,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jad.2025.120485","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:43:28Z","timestamp":1761929008000},"page":"120485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"PB","title":["Psilocybin use in bipolar disorder: A comprehensive review"],"prefix":"10.1016","volume":"394","author":[{"given":"Andr\u00e9","family":"Do","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Cloutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"H\u00e9bert-Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charl\u00e8ne","family":"Thauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jad.2025.120485_bb0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamapsychiatry.2023.4685","article-title":"Single-dose synthetic psilocybin with psychotherapy for treatment-resistant bipolar type II major depressive episodes: a nonrandomized open-label trial","volume":"81","author":"Aaronson","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2025.120485_bb0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.jad.2025.120485_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/acps.12994","article-title":"ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression","volume":"139","author":"Bahji","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"12","key":"10.1016\/j.jad.2025.120485_bb0020","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1176\/appi.ajp.22010073","article-title":"A case of prolonged mania, psychosis, and severe depression after psilocybin use: implications of increased psychedelic drug availability","volume":"179","author":"Barber","year":"2022","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.120485_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/bdi.13016","article-title":"Bipolar disorder: trimodal age-at-onset distribution","volume":"23","author":"Bolton","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.120485_bb0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jad.2023.10.161","article-title":"Adjunctive continuous theta burst stimulation for major depressive disorder or bipolar depression: a meta-analysis of randomized controlled studies","volume":"346","author":"Cai","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"15","key":"10.1016\/j.jad.2025.120485_bb0035","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jad.2025.120485_bb0040","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s11845-021-02668-2","article-title":"Psychedelic perceptions: mental health service user attitudes to psilocybin therapy","volume":"191","author":"Corrigan","year":"2022","journal-title":"Ir. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.jad.2025.120485_bb0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.120485_bb0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.jad.2025.120485_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279073","article-title":"\u201cA sense of the bigger picture:\u201d a qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use","volume":"17","author":"DellaCrosse","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jad.2025.120485_bb0060","article-title":"Suicide risk in bipolar disorder: a brief review","volume":"55","author":"Dome","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jad.2025.120485_bb0065","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2147\/NDT.S273503","article-title":"Treatment-resistant bipolar depression: therapeutic trends, challenges and future directions","volume":"18","author":"Elsayed","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.120485_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jad.2016.11.021","article-title":"The difficult lives of individuals with bipolar disorder: a review of functional outcomes and their implications for treatment","volume":"209","author":"Gitlin","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2025.120485_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0327(03)00161-7","article-title":"Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up","volume":"81","author":"Goldberg","year":"2004","journal-title":"J. Affect. Disord."},{"issue":"18","key":"10.1016\/j.jad.2025.120485_bb0080","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.120485_bb0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fpsyt.2019.00304","article-title":"Patients\u2019, carers\u2019, and the public\u2019s perspectives on electroconvulsive therapy","volume":"10","author":"Griffiths","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.120485_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jad.2025.120485_bb0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1399-5618.2008.00604.x","article-title":"Quality of life in bipolar disorder patients: a comparison with a general population sample","volume":"10","author":"Gutierrez-Rojas","year":"2008","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.120485_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115531","article-title":"Psilocybin-assisted therapy for depression: a systematic review and meta-analysis","volume":"329","author":"Haikazian","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.120485_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1221131","article-title":"Manic episode following psilocybin use in a man with bipolar II disorder: a case report","volume":"14","author":"Halim","year":"2023","journal-title":"Front. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2025.120485_bb0110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bdi.13095","article-title":"An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: a case report","volume":"23","author":"Hendin","year":"2021","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.jad.2025.120485_bb0115","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2023.535","article-title":"Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial","volume":"9","author":"Husain","year":"2023","journal-title":"BJPsych Open"},{"issue":"1","key":"10.1016\/j.jad.2025.120485_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"12","key":"10.1016\/j.jad.2025.120485_bb0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/2045125318804364","article-title":"Medication nonadherence in bipolar disorder: a narrative review","volume":"8","author":"Jawad","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jad.2025.120485_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13060909","article-title":"The role of ketamine in the treatment of bipolar depression: a scoping review","volume":"13","author":"Jawad","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.jad.2025.120485_bb0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.05.012","article-title":"The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act","volume":"142","author":"Johnson","year":"2018","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.jad.2025.120485_bb0140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120485_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41380-023-02045-8","article-title":"Repetitive transcranial magnetic stimulation for bipolar depression: a systematic review and pairwise and network meta-analysis","volume":"29","author":"Kishi","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.120485_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104032","article-title":"Deep transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled studies","volume":"96","author":"Lan","year":"2024","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jad.2025.120485_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1416420","article-title":"Psilocybin for major depressive disorder: a systematic review of randomized controlled studies","volume":"15","author":"Li","year":"2024","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.120485_bb0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40263-021-00877-y","article-title":"Molecular mechanisms of psilocybin and implications for the treatment of depression","volume":"36","author":"Ling","year":"2022","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.jad.2025.120485_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/psymed.2024.0032","article-title":"Psilocybin-assisted psychotherapy for treatment-resistant depression in bipolar II disorder","volume":"3","author":"Meshkat","year":"2025","journal-title":"Psychedelic Med."},{"key":"10.1016\/j.jad.2025.120485_bb0170","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jad.2024.12.044","article-title":"Psychedelic use and bipolar disorder - an investigation of recreational use and its impact on mental health","volume":"373","author":"Meyer","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2025.120485_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/02698811221131997","article-title":"Risks and benefits of psilocybin use in people with bipolar disorder: an international web-based survey on experiences of \u2018magic mushroom\u2019 consumption","volume":"37","author":"Morton","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jad.2025.120485_bb0180","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/a-1524-2794","article-title":"Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports","volume":"54","author":"Nayak","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10.1016\/j.jad.2025.120485_bb0185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jad.2025.120485_bb0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/07067437221111371","article-title":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force report: serotonergic psychedelic treatments for major depressive disorder","volume":"68","author":"Rosenblat","year":"2023","journal-title":"Can. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.jad.2025.120485_bb0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.medj.2024.01.005","article-title":"Psilocybin-assisted psychotherapy for treatment resistant depression: a randomized clinical trial evaluating repeated doses of psilocybin","volume":"5","author":"Rosenblat","year":"2024","journal-title":"Med"},{"issue":"6","key":"10.1016\/j.jad.2025.120485_bb0200","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00213-022-06083-y","article-title":"Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review","volume":"239","author":"Sarparast","year":"2022","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jad.2025.120485_bb0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/10673220600748486","article-title":"Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome","volume":"14","author":"Shirzadi","year":"2006","journal-title":"Harv. Rev. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2025.120485_bb0210","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/NMD.0000000000001489","article-title":"From mushrooms to myolysis: a case of rhabdo in psilocybin-induced mood and psychotic disorder","volume":"210","author":"Suleiman","year":"2022","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jad.2025.120485_bb0215","article-title":"Regulatory alignment of psilocybin clinical trials in major depressive disorder on ClinicalTrials.gov: a cross-sectional analysis","author":"Swieczkowski","year":"2025","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2025.120485_bb0220","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.jad.2025.120485_bb0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725019275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725019275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:09:37Z","timestamp":1764220177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725019275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"alternative-id":["S0165032725019275"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120485","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psilocybin use in bipolar disorder: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120485"}}